Skip to main content
. 2015 Jul 3;47(7):e171. doi: 10.1038/emm.2015.37

Figure 3.

Figure 3

Honokiol regulated the expression of PTX3 and inflammatory response in PA-induced HUVECs model. PTX-3 levels from the enzyme-linked immunosorbent assay (ELISA) (a), western blotting (b) and reverse-transcriptase PCR (RT-PCR) (c) in HUVECs after treatment with vehicle, 0.5 mM PA, PA plus 10 μM honokiol or PA plus an inhibitor of IKK-2 (TPCA-1, 30 μM) for 48 h. (d) Protein expression of IkB and p-IkB in HUVECs after treatment with vehicle, 0.5 mM PA or PA plus 10 μM honokiol for 48 h. (e) Protein expression of p50 and p65 in HUVECs after treatment with vehicle, 0.5 mM PA or PA plus 10 μM honokiol for 48 h. (f) IL-6, IL-8 and MCP-1 levels measured by the ELISA assay in HUVECs after treatment with vehicle, 0.5 mM PA or PA plus 10 μM honokiol for 48 h. Data are mean±s.d., n=3 in each group. *P<0.05, versus untreated group. #P<0.05 and ##P<0.01, versus 0.5 mM PA treatment group.